logo
logo

Artificial Raises $21.5M To Accelerate Life Science Breakthroughs

May 18, 2021•about 4 years ago

Amount Raised

$21.5 Million

Palo Alto

Description

Artificial, a software company providing a first-of-its-kind lab automation platform, announced today the close of their $21.5M Series A investment round. The round was led by M12, Microsoft’s venture fund, along with Playground Global and AME Cloud Ventures. Artificial will use the investment to accelerate product development, expand their world-class team, and further their life science partnerships so that scientific breakthroughs can happen faster and more efficiently.

Company Information

Company

Artificial

Location

Palo Alto, California, United States

About

Artificial empowers every lab to realize the benefits of automation by providing a first-of-its-kind software platform that keeps the human-in-the-loop. Artificial’s aLab Suite orchestrates everything that happens in a lab, including the manual tasks that still make up much of today’s lab work, to generate robust reliability and reproducibility. By bringing together the robotics, automation, data, and people all on one single easy-to-use platform, labs are enabled to adopt automation earlier and easily scale their operations so they can focus on their next breakthrough, not the complexities of their automation. For more information, please visit www.artificial.com.

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech